Specialty Pharma Journal Specialty, Precision & Technology

Ovarian cancer has proven to be a formidable foe. This form of cancer remains difficult …

Researchers at The University of Texas MD Anderson Cancer Center have developed a new personalized …

LAVAL, Quebec, Nov. 1, 2016 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: …

STOCKHOLM–(BUSINESS WIRE)–Regulatory News:  Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company has entered …

HAMPTON, N.J., and NEW HAVEN, Conn., Nov. 01, 2016 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. …

Tuesday, November 1, 2016 – 6:30am EDT — Pfizer Inc. announced today the discontinuation of the …

Basel, November 1, 2016 – Novartis announced today that the US Food and Drug Administration …

SYDNEY, Oct. 30, 2016 /PRNewswire/ — Australian oncology-focused biotechnology company, Novogen Ltd (ASX: NRT; NASDAQ: …

ST. PAUL, Minn.–(BUSINESS WIRE)–St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced …

October 28, 2016– A new American Cancer Society study finds that incidence of anal cancer …

TEL AVIV, Israel, October 31, 2016 /PRNewswire/ — Therapix Biosciences, (OTCQB: THXBY) (TASE: THXBY.TA) the …

BOSTON–(BUSINESS WIRE)–NantHealth, Inc.(Nasdaq: NH), a leading next-generation, evidence-based, personalized healthcare company, the Chan Soon-Shiong Institute …

Paris and Tarrytown, N.Y. – October 28, 2016 – Sanofi and Regeneron Pharmaceuticals, Inc. today …

WOODCLIFF LAKE, N.J., Oct. 28, 2016 /PRNewswire/ — Eisai Inc. announced today the initiation of …

DUBLIN and BOSTON, Oct. 27, 2016 /PRNewswire/ — Allergan plc. (NYSE: AGN), a leading global pharmaceutical …